Ahrens Investment Partners’s Advanced Micro Devices AMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
$222K Buy
+2,261
New +$184K 0.11% 129
2022
Q3
Sell
-4,273
Closed -$327K 188
2022
Q2
$327K Buy
4,273
+455
+12% +$42.6K 0.14% 116
2022
Q1
$417K Buy
3,818
+78
+2% +$9.31K 0.13% 119
2021
Q4
$538K Sell
3,740
-300
-7% -$40.3K 0.24% 88
2021
Q3
$416K Buy
4,040
+465
+13% +$47.5K 0.2% 121
2021
Q2
$336K Buy
3,575
+540
+18% +$43.6K 0.16% 153
2021
Q1
$238K Buy
3,035
+10
+0.3% +$861 0.12% 165
2020
Q4
$277K Sell
3,025
-345
-10% -$29.8K 0.15% 134
2020
Q3
$276K Sell
3,370
-780
-19% -$57.9K 0.18% 121
2020
Q2
$218K Sell
4,150
-1,200
-22% -$63.6K 0.13% 140
2020
Q1
$243K Buy
+5,350
New +$258K 0.17% 97

Other funds holding AMD

Ahrens Investment Partners's AMD Position: Q1 2023 in Review

Ahrens Investment Partners opened a new position in Advanced Micro Devices (AMD) in Q1 2023: 2,261 shares worth $222K. The stake represents 0.11% of the portfolio and ranks #129 among its holdings. This is a return to the name: Ahrens Investment Partners previously reported a position in AMD as recently as Q2 2022.

Ahrens Investment Partners first reported a position in AMD in Q1 2020 and has held it in 11 quarters since. The position peaked at $538K in Q4 2021. 1,825 funds tracked by Wall St. Rank hold AMD as of Q1 2023.

  • Ahrens Investment Partners held 2,261 shares of Advanced Micro Devices worth $222K as of Q1 2023.
  • Advanced Micro Devices was a new Ahrens Investment Partners position in Q1 2023.
  • Advanced Micro Devices made up 0.11% of Ahrens Investment Partners's portfolio in Q1 2023, its #129 holding.
  • Ahrens Investment Partners first reported a position in Advanced Micro Devices in Q1 2020 and has held it in 11 quarters since.
  • Ahrens Investment Partners's Advanced Micro Devices position peaked at $538K in Q4 2021.
  • 1,825 funds tracked by Wall St. Rank held Advanced Micro Devices as of Q1 2023.

Based on Ahrens Investment Partners's 13F filing for Q1 2023, filed 24 Apr 2023.